Rare case of catastrophic antiphospholipid syndrome with spontaneous intracranial haemorrhage.
Document Type
Article
Publication Date
3-20-2019
Publication Title
BMJ Case Rep
Abstract
Catastrophic antiphospholipid syndrome (CAPS) is a rare but severe form of antiphospholipid syndrome (APS). The syndrome manifests itself as a rapidly progressive multiorgan failure that is believed to be caused by widespread micro-thrombosis. Seldom does bleeding comanifest with thrombosis. We present a patient with APS who presented with nausea, vomiting and fatigue, and rapidly progressed into multiorgan failure before being diagnosed with CAPS. The clinical course was complicated by an atraumatic intracranial haemorrhage which demanded discontinuation of anticoagulation. The patient was treated with high dose steroid, intravenous immunoglobulin, followed by weekly rituximab infusion. Although the trigger for CAPS was not obvious during her hospital stay, she was diagnosed with acute cytomegalovirus (CMV) infection soon after discharge. In this case report, we explore the differential diagnoses of CAPS, investigate the possibility of CMV infection as a potential trigger, present the therapeutic challenges of anticoagulation and discuss the emerging use of rituximab.
Volume
12
Issue
3
First Page
e227171
Recommended Citation
Adhikari A, Chisti MM, Bastola S, Kc O. Rare case of catastrophic antiphospholipid syndrome with spontaneous intracranial haemorrhage. BMJ Case Rep. 2019 Mar 20;12(3):e227171. doi: 10.1136/bcr-2018-227171. PMID: 30898956; PMCID: PMC6453383.
DOI
10.1136/bcr-2018-227171
ISSN
1757-790X
PubMed ID
30898956